This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
After evaluating thousands of articles and hundreds of candidates, a brain-penetrant pre-mRNA splicing modulator, a gut-restricted candidate for Parkinson’s disease…
Article
9 months ago ●
1 min read
Since the 2014 discoveries that thalidomide-like compounds “glue” together the cereblon (CRBN) unit of the ubiquitin E3 ligase complex and…
Article
9 months ago ●
13 mins read
Today, ozanimod is a likely megablockbuster drug approved for ulcerative colitis and multiple sclerosis. But before it became the first…
Article
10 months ago ●
9 mins read
In a recent webinar, we surveyed our audience and were surprised to see that a significant majority of attendees thought…
resource
11 months ago ●
8 mins read
This article explains what Phase II drug metabolism is, contains a poster summarizing common enzyme-mediated bioconjugation reactions, and provides interesting…
resource
1 year ago ●
22 mins read
How a Follow-on Drug Can Create Value After a First-in-Class Drug Novel drugs can make a big impact in two…
resource
1 year ago ●
4 mins read
Load More
